Related references
Note: Only part of the references are listed.Thrombolysis in elderly stroke patients in Italy (TESPI) trial and updated meta-analysis of randomized controlled trials
Svetlana Lorenzano et al.
INTERNATIONAL JOURNAL OF STROKE (2021)
Computed tomography perfusion in stroke mimics
Ames E. Siegler et al.
INTERNATIONAL JOURNAL OF STROKE (2020)
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke The EXTEND-IA TNK Part 2 Randomized Clinical Trial
Bruce C. V. Campbell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis
Konark Malhotra et al.
NEUROLOGY (2020)
Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort
P. Alan Barber et al.
NEUROLOGY (2020)
Eligibility for intravenous thrombolysis in acute ischemic stroke patients presenting in the 4.5-9 h window
Klearchos Psychogios et al.
NEURORADIOLOGY (2020)
Benefit of Intravenous Thrombolysis in Acute Ischemic Stroke Patients With High Cerebral Microbleed Burden
Ludwig Schlemm et al.
STROKE (2020)
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants A Systematic Review and Meta-Analysis
Shima Shahjouei et al.
STROKE (2020)
Bridging Therapy or IV Thrombolysis in Minor Stroke with Large Vessel Occlusion
Pierre Seners et al.
ANNALS OF NEUROLOGY (2020)
Intravenous thrombolysis for large vessel or distal occlusions presenting with mild stroke severity
G. Tsivgoulis et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset A Randomized Controlled Trial
Masatoshi Koga et al.
STROKE (2020)
Intravenous thrombolysis in patients with chronic kidney disease A systematic review and meta-analysis
Konark Malhotra et al.
NEUROLOGY (2020)
Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years Pooled Analyses of Individual Patient Data
Erich Bluhmki et al.
STROKE (2020)
Endovascular Treatment for Acute Ischemic Stroke in Patients on Oral Anticoagulants Results From the MR CLEAN Registry
Robert-Jan B. Goldhoorn et al.
STROKE (2020)
Large Vessel Occlusion Strokes After the DIRECT-MT and SKIP Trials Is the Alteplase Syringe Half Empty or Half Full?
Raul G. Nogueira et al.
STROKE (2020)
Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances
Brian Scott Alper et al.
BMJ EVIDENCE-BASED MEDICINE (2020)
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
Goetz Thomalla et al.
LANCET (2020)
Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit
Henry Zhao et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review
David Giannandrea et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
eTICI reperfusion: defining success in endovascular stroke therapy
David S. Liebeskind et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2019)
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
Craig S. Anderson et al.
LANCET (2019)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Ewgenia Barow et al.
JAMA NEUROLOGY (2019)
Association of Elevated Blood Pressure Levels with Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A Systematic Review and Meta-Analysis
Konark Malhotra et al.
JOURNAL OF STROKE (2019)
Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection
Peter Ringleb et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
Bruce C. Campbell et al.
LANCET (2019)
Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial
Andrei Alexandrov et al.
LANCET NEUROLOGY (2019)
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
H. Ma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Association of Baseline Hyperglycemia With Outcomes of Patients With and Without Diabetes With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Propensity Score-Matched Analysis From the SITS-ISTR Registry
Georgios Tsivgoulis et al.
DIABETES (2019)
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial
Karen C. Johnston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Intravenous thrombolysis for suspected ischemic stroke with seizure at onset
Alexandros A. Polymeris et al.
ANNALS OF NEUROLOGY (2019)
Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials
Adrian M. Burgos et al.
STROKE (2019)
EXTEND Trial Towards a More Inclusive But Complex Thrombolysis
Enrique C. Leira et al.
STROKE (2019)
Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction: Case Series and Systematic Review
Joao Pedro Marto et al.
STROKE (2019)
Mechanical thrombectomy outcomes in large vessel stroke with high international normalized ratio
Abhi Pandhi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum
Adam Cuker et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries
Diana Aguiar de Sousa et al.
EUROPEAN STROKE JOURNAL (2019)
European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE)
Guillaume Turc et al.
EUROPEAN STROKE JOURNAL (2019)
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018
Niaz Ahmed et al.
EUROPEAN STROKE JOURNAL (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
More extensive white matter hyperintensity is linked with higher risk of remote intracerebral hemorrhage after intravenous thrombolysis
Y. Chen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Predictors of symptomatic intracranial haemorrhage in off-label thrombolysis: an analysis of the Safe Implementation of Treatments in Stroke registry
S. Mundiyanapurath et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials
Werner Hacke et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants
E. Touze et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design
Sharon D. Yeatts et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits The PRISMS Randomized Clinical Trial
Pooja Khatri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study
Ramin Zand et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial
Guofang Chen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
G. Thomalla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effects of Prehospital Thrombolysis in Stroke Patients With Prestroke Dependency
Christian H. Nolte et al.
STROKE (2018)
Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study
Ramin Zand et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Intravenous Thrombolysis for Ischemic Stroke Patients on Dual Antiplatelets
Georgios Tsivgoulis et al.
ANNALS OF NEUROLOGY (2018)
Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials
Babikir Kheiri et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke
Georgios Tsivgoulis et al.
NEUROLOGY (2018)
Reversal of Vitamin K Antagonist Therapy Before Thrombolysis for Acute Ischemic Stroke
Nicolas Chausson et al.
STROKE (2018)
Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations
Kazunori Toyoda et al.
JOURNAL OF STROKE (2018)
European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke
Blanca Fuentes et al.
EUROPEAN STROKE JOURNAL (2018)
Stroke outcomes are worse with larger leukoaraiosis volumes
Wi-Sun Ryu et al.
BRAIN (2017)
Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion
H. C. Diener et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Endovascular stroke therapy may be safe in patients with elevated international normalized ratio
Sibu Mundiyanapurath et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2017)
Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke
Grant Mair et al.
STROKE (2017)
NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population
Aliona Nacu et al.
STROKE (2017)
Acute stroke differential diagnosis: Stroke mimics
Pedro Vilela
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis
Georgios Tsivgoulis et al.
JOURNAL OF NEUROLOGY (2017)
Another Enchantment From ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Are Savings and Safety More Salutary Than Efficacy?
Peter D. Schellinger et al.
STROKE (2017)
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia
Ashkan Mowla et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
MRI based thrombolysis for FLAIR-negative stroke patients within 4.5-6 h after symptom onset
Xiao-Er Wei et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
Nicola Logallo et al.
LANCET NEUROLOGY (2017)
Thrombolytic Therapy in Acute Ischemic Stroke in Patients Not Fulfilling Conventional Criteria
Man Sum Chi et al.
NEUROLOGIST (2017)
Tenecteplase in ischemic stroke offers improved recanalization Analysis of 2 trials
Andrew Bivard et al.
NEUROLOGY (2017)
Low-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)
Thompson G. Robinson et al.
STROKE (2017)
Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis
Susan J. Carr et al.
STROKE (2017)
Thrombolysis in Postoperative Stroke
Nicolas Voelkel et al.
STROKE (2017)
Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis Individual Patient Data Meta-Analysis
Andreas Charidimou et al.
STROKE (2017)
Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)
Andrew D. Barreto et al.
STROKE (2017)
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia
Ashkan Mowla et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke Secondary Analysis of the ENCHANTED Randomized Clinical Trial
Xia Wang et al.
JAMA NEUROLOGY (2017)
Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
David J. Seiffge et al.
JOURNAL OF STROKE (2017)
Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated With Non-Vitamin K Antagonist Oral Anticoagulants An Editorial Review
Georgios Tsivgoulis et al.
STROKE (2017)
Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke
Ying Xian et al.
CIRCULATION (2017)
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Bart M. Demaerschalk et al.
STROKE (2016)
Cerebral White Matter Lesions and Post-Thrombolytic Remote Parenchymal Hemorrhage
Sami Curtze et al.
ANNALS OF NEUROLOGY (2016)
Post-thrombolytic blood pressure and symptomatic intracerebral hemorrhage
T. Waltimo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
William N. Whiteley et al.
LANCET NEUROLOGY (2016)
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
Eivind Berge et al.
LANCET NEUROLOGY (2016)
Restriction of therapy mainly explains lower thrombolysis rates in reduced stroke service levels
Christoph Gumbinger et al.
NEUROLOGY (2016)
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
C. S. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Jan C. Purrucker et al.
STROKE (2016)
Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study) How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?
Daniel Strbian et al.
STROKE (2016)
Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke A Meta-Analysis (v1)
Andreas Charidimou et al.
STROKE (2016)
Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients
Wei Li et al.
STROKE (2016)
Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke
Henrik Gensicke et al.
STROKE (2016)
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes A Pooled Analysis of 9 Trials
Kennedy R. Lees et al.
STROKE (2016)
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies
Shengyuan Luo et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden A Meta-analysis
Georgios Tsivgoulis et al.
JAMA NEUROLOGY (2016)
A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)
Aliona Nacu et al.
BMC NEUROLOGY (2015)
Recanalization Therapies in Acute Ischemic Stroke Patients Impact of Prior Treatment With Novel Oral Anticoagulants on Bleeding Complications and Outcome A Pilot Study
David J. Seiffge et al.
CIRCULATION (2015)
Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions
Georgios Tsivgoulis et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial
Peter D. Schellinger et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Safety and outcomes of intravenous thrombolysis in dissection-related ischemic stroke: an international multicenter study and comprehensive meta-analysis of reported case series
Georgios Tsivgoulis et al.
JOURNAL OF NEUROLOGY (2015)
Chronic kidney disease and intravenous thrombolysis in acute stroke: A systematic review and meta-analysis
Jin-Man Jung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
Joanna M. Wardlaw et al.
LANCET NEUROLOGY (2015)
Alteplase versus tenecteplase for thrombolysis after Cross Mark ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study
Xuya Huang et al.
LANCET NEUROLOGY (2015)
Development and validation of a simplified Stroke-Thrombolytic Predictive Instrument
David M. Kent et al.
NEUROLOGY (2015)
Systemic thrombolysis in acute ischemic stroke patients with unruptured intracranial aneurysms
Nitin Goyal et al.
NEUROLOGY (2015)
Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke
Eivind Berge et al.
STROKE (2015)
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial
Opeolu Adeoye et al.
STROKE (2015)
Alteplase for Acute Ischemic Stroke Outcomes by Clinically Important Subgroups in the Third International Stroke Trial
Richard I. Lindley et al.
STROKE (2015)
Tenecteplase-Tissue-Type Plasminogen Activator Evaluation for Minor Ischemic Stroke With Proven Occlusion
Shelagh B. Coutts et al.
STROKE (2015)
Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours A Comparative Effectiveness and Safety Study
Beom Joon Kim et al.
STROKE (2015)
Safety of Intravenous Thrombolysis in Stroke Mimics Prospective 5-Year Study and Comprehensive Meta-Analysis
Georgios Tsivgoulis et al.
STROKE (2015)
Acute Stroke with Concomitant Acute Myocardial Infarction: Will You Thrombolyse?
Rita Maciel et al.
JOURNAL OF STROKE (2015)
Selection for delayed intravenous alteplase treatment based on a prognostic score
Rachael L. Fulton et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials
Xiding Pan et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications
Pierre Seners et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Recombinant Tissue-Type Plasminogen Activator Plus Eptifibatide Versus Recombinant Tissue-Type Plasminogen Activator Alone in Acute Ischemic Stroke Propensity Score-Matched Post Hoc Analysis
Opeolu Adeoye et al.
STROKE (2015)
Thrombolysis in patients with prior stroke within the last 3 months
M. R. Heldner et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications
Michal Harsany et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0.6 mg/kg (THAWS) Trial
Masatoshi Koga et al.
INTERNATIONAL JOURNAL OF STROKE (2014)
Outcomes following sonothrombolysis in severe acute ischemic stroke: subgroup analysis of the CLOTBUST trial
Kristian Barlinn et al.
INTERNATIONAL JOURNAL OF STROKE (2014)
Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke
Manuel Cappellari et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson et al.
LANCET (2014)
Renal Dysfunction and Thrombolytic Therapy in Patients With Acute Ischemic Stroke A Systematic Review and Meta-Analysis
Zilong Hao et al.
MEDICINE (2014)
Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses
Xiaoling Liao et al.
STROKE (2014)
Role of Preexisting Disability in Patients Treated With Intravenous Thrombolysis for Ischemic Stroke
Michal Karlinski et al.
STROKE (2014)
Wake-up stroke: clinical characteristics, imaging findings, and treatment option - an update
D. Leander Rimmele et al.
FRONTIERS IN NEUROLOGY (2014)
Safety of off-label stroke treatment with tissue plasminogen activator
C. E. Kvistad et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Neurologic Complications of Infective Endocarditis
Amy A. Pruitt
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2013)
Waiting for Platelet Counts Causes Unsubstantiated Delay of Thrombolysis Therapy
L. Breuer et al.
EUROPEAN NEUROLOGY (2013)
Thrombolysis for stroke caused by infective endocarditis: an illustrative case and review of the literature
Elodie Ong et al.
JOURNAL OF NEUROLOGY (2013)
Does pre-existing cognitive impairment no-dementia influence the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia?
Kei Murao et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Intravenous Alteplase for acute ischemic stroke in patients with current malignant neoplasm
Manuel Cappellari et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
Peter Sandercock et al.
LANCET NEUROLOGY (2013)
Physiological and modeling evidence for focal transcranial electrical brain stimulation in humans: A basis for high-definition tDCS
Dylan Edwards et al.
NEUROIMAGE (2013)
IV thrombolysis and renal function
Henrik Gensicke et al.
NEUROLOGY (2013)
The Effects of Alteplase 3 to 6 Hours After Stroke in the EPITHET-DEFUSE Combined Dataset Post Hoc Case-Control Study
Toshiyasu Ogata et al.
STROKE (2013)
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke-Enhanced Regimen Stroke Trial
Arthur M. Pancioli et al.
STROKE (2013)
Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria Part 1: Rapidly Improving Stroke Symptoms
Steven R. Levine et al.
STROKE (2013)
Thrombolysis in Stroke Despite Contraindications or Warnings?
Benedikt Frank et al.
STROKE (2013)
Safety of Thrombolysis in Stroke Mimics Results From a Multicenter Cohort Study
Sanne M. Zinkstok et al.
STROKE (2013)
Thrombolysis for Ischemic Stroke Associated With Infective Endocarditis Results From the Nationwide Inpatient Sample
Ganesh Asaithambi et al.
STROKE (2013)
Reversal of Warfarin Anticoagulation with Prothrombin Complex Concentrate before Thrombolysis for Acute Stroke
Shirin Jalini et al.
CEREBROVASCULAR DISEASES (2012)
Off-label intravenous thrombolysis in acute stroke
M. Guillan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database
S. T. Engelter et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe
Michal Karlinski et al.
INTERNATIONAL JOURNAL OF STROKE (2012)
Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator
Ying Xian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial
Sanne M. Zinkstok et al.
LANCET (2012)
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Peter Sandercock et al.
LANCET (2012)
Intravenous Thrombolysis in the Treatment of Ischemic Stroke Due to Spontaneous Artery Dissection
Maja Stefanovic-Budimkic et al.
NEUROLOGIST (2012)
Perfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial
Patrik Michel et al.
NEURORADIOLOGY (2012)
A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
Mark Parsons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score
Michael Mazya et al.
STROKE (2012)
Systemic Thrombolysis in Patients With Acute Ischemic Stroke and Internal Carotid ARtery Occlusion The ICARO Study
Maurizio Paciaroni et al.
STROKE (2012)
The Argatroban and Tissue-Type Plasminogen Activator Stroke Study Final Results of a Pilot Safety Study
Andrew D. Barreto et al.
STROKE (2012)
Adjunctive and Alternative Approaches to Current Reperfusion Therapy
Andrew D. Barreto et al.
STROKE (2012)
Ninety-Day Outcome Rates of a Prospective Cohort of Consecutive Patients With Mild Ischemic Stroke
Pooja Khatri et al.
STROKE (2012)
Hemorrhagic complications after systemic thrombolysis in acute stroke patients with abnormal baseline coagulation
F. Brunner et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Current status of intravenous thrombolysis for acute ischemic stroke in Asia
Vijay K. Sharma et al.
INTERNATIONAL JOURNAL OF STROKE (2011)
GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4-5 h if symptom onset (PRE-FLAIR): a multicentre observational study
Goetz Thomalla et al.
LANCET NEUROLOGY (2011)
Population-based study of wake-up strokes
J. Mackey et al.
NEUROLOGY (2011)
Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke A Meta-Analysis of Individual Patient Data
Sanne M. Zinkstok et al.
STROKE (2011)
Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China Analysis of the Results From the Chinese National Stroke Registry (CNSR)
Yilong Wang et al.
STROKE (2011)
Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator Findings From Get With The Guidelines-Stroke
Eric E. Smith et al.
STROKE (2011)
Association of Admission Blood Glucose and Outcome in Patients Treated With Intravenous Thrombolysis
Niaz Ahmed et al.
ARCHIVES OF NEUROLOGY (2010)
Intracranial Hemorrhage Following Thrombolytic Use for Stroke Caused by Infective Endocarditis
Parita Bhuva et al.
NEUROCRITICAL CARE (2010)
Cardiac Rupture After Intravenous t-PA Administration in Acute Ischemic Stroke
Amar Dhand et al.
NEUROCRITICAL CARE (2010)
Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke
Atte Meretoja et al.
STROKE (2010)
Safety and Efficacy of Ultrasound-Enhanced Thrombolysis A Comprehensive Review and Meta-Analysis of Randomized and Nonrandomized Studies
Georgios Tsivgoulis et al.
STROKE (2010)
Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke Results of a Prematurely Terminated Randomized Clinical Trial
E. Clarke Haley et al.
STROKE (2010)
Outcomes of Thrombolytic Therapy for Acute Ischemic Stroke in Chinese Patients The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study
A-Ching Chao et al.
STROKE (2010)
Effects of 0.6 mg/kg Intravenous Alteplase on Vascular and Clinical Outcomes in Middle Cerebral Artery Occlusion Japan Alteplase Clinical Trial II (J-ACT II)
Etsuro Mori et al.
STROKE (2010)
Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice The Japan post-Marketing Alteplase Registration Study (J-MARS)
Jyoji Nakagawara et al.
STROKE (2010)
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
Erich Bluhmki et al.
LANCET NEUROLOGY (2009)
Cerebral microbleeds: a guide to detection and interpretation
Steven M. Greenberg et al.
LANCET NEUROLOGY (2009)
Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke
N. S. Rost et al.
NEUROLOGY (2009)
Is it Time to Reassess the SITS-MOST Criteria for Thrombolysis? A Comparison of Patients With and Without SITS-MOST Exclusion Criteria
Marta Rubiera et al.
STROKE (2009)
Pre-Tissue Plasminogen Activator Blood Pressure Levels and Risk of Symptomatic Intracerebral Hemorrhage
Georgios Tsivgoulis et al.
STROKE (2009)
Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients General Outcomes and Prognostic Factors From the SAMURAI Register
Kazunori Toyoda et al.
STROKE (2009)
Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials
Brett Cucchiara et al.
STROKE (2009)
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee
Werner Hacke et al.
CEREBROVASCULAR DISEASES (2008)
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
Stephen M. Davis et al.
LANCET NEUROLOGY (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial
Mei Yong et al.
STROKE (2008)
Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial
Mei Yong et al.
STROKE (2008)
The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke The CLEAR Stroke Trial
Arthur M. Pancioli et al.
STROKE (2008)
Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion -: Results from a randomized study
Juergen Eggers et al.
STROKE (2008)
Ultrasound enhanced thrombolysis in acute arterial ischemia
Georgios Tsivgoulis et al.
ULTRASONICS (2008)
Dissections of brain-supplying arteries
Louis R. Caplan
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial?
Werner Hacke et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Ultrasound-enhanced thrombolysis in acute ischemic stroke: Potential, failures, and safety
Georgios Tsivgoulis et al.
NEUROTHERAPEUTICS (2007)
Usefulness of checking platelet count before thrombolysis in acute ischemic stroke
Brett L. Cucchiara et al.
STROKE (2007)
Neurological symptoms in type A aortic dissections
Charly Gaul et al.
STROKE (2007)
Hemorrhagic complications after off-label thrombolysis for ischemic stroke
Aitziber Aleu et al.
STROKE (2007)
Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset - Japan Alteplase Clinical Trial (J-ACT)
Takenori Yamaguchi et al.
STROKE (2006)
Extent of early ischemic changes on computed tomography (CT) before thrombolysis - Prognostic value of the Alberta Stroke Program Early CT Score in ECASS II
I Dzialowski et al.
STROKE (2006)
Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke
M Rubiera et al.
STROKE (2005)
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
MD Hill et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke
AV Alexandrov et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effect of ultrasound on thrombolysis of middle cerebral artery occlusion
J Eggers et al.
ANNALS OF NEUROLOGY (2003)
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator
AV Alexandrov et al.
NEUROLOGY (2002)
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
A Bruno et al.
NEUROLOGY (2002)
The stroke patient who woke up - Clinical and radiological features, including diffusion and perfusion MRI
JN Fink et al.
STROKE (2002)
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke
SC Patel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study
GW Albers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
The rtPA (Alteplase) 0-to 6-hour acute stroke trial, part A (A0276g) - Results of a double-blind, placebo-controlled, multicenter study
WM Clark et al.
STROKE (2000)
Effectiveness of t-PA in acute ischemic stroke - Outcome relates to appropriateness
AM Buchan et al.
NEUROLOGY (2000)
Share Paper
